Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity

被引:134
作者
Cohn, JS
Patterson, BW
Uffelman, KD
Davignon, J
Steiner, G
机构
[1] Clin Res Inst Montreal, Hyperlipidemia & Atherosclerosis Res Grp, Montreal, PQ H2W 1R7, Canada
[2] Washington Univ, Sch Med, St Louis, MO 63110 USA
[3] Toronto Gen Hosp, Toronto, ON M5G 2C4, Canada
关键词
D O I
10.1210/jc.2003-032056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Overweight individuals with reduced insulin sensitivity often have mild to moderate hypertriglyceridemia. To investigate the role of apolipoprotein (apo) C-III metabolism in the etiology of hypertriglyceridemia in these individuals, we investigated 10 male subjects with different body weights ( body mass index, 24 - 34 kg/m(2)) and insulin sensitivity (homeostasis model assessment, 4.7 - 35.0). Total plasma and very-low-density lipoprotein ( VLDL) apoC-III kinetics, as well as VLDL triglyceride (TG) and VLDL apoB kinetics, were measured with iv injected stable isotopes. The apoC-III, TG, and apoB levels in VLDL ranged from 2.9 - 18.2 mg/dl, 0.49 - 2.89 mmol/ liter, and 6.7 - 29.3 mg/dl, respectively. Mean production rates (PRs) were: VLDL apoC-III, 20.2 +/- 4.1 mumol/d ( range, 8.0 - 44.8); VLDLTG, 26.9 +/- 4.6 mmol/d ( range, 10.2 - 51.1); and VLDL apoB, 4.4 +/- 0.8 mumol/d ( range, 1.5 - 9.1). VLDL apoC-III PRs were significantly correlated with body mass index, homeostasis model assessment, and plasma TG ( r = 0.66, P < 0.05; r = 0.80, P < 0.01; r = 0.95, P < 0.001, respectively). Similar correlations were found for plasma apoC-III PRs ( r = 0.70, P< 0.05; r = 0.67, P < 0.05; r = 0.80, P < 0.01, respectively). Fractional catabolic rates (FCRs) were not significantly related to metabolic variables. VLDL TG levels were strongly related to VLDL apoC-III levels ( r = 0.99, P< 0.001) and VLDL apoC-III PRs ( r = 0.94, P< 0.001). VLDL apoC-III levels were more strongly correlated with VLDL TG PRs ( r = 0.81, P < 0.01) than with VLDL TG FCRs or VLDL apoB FCRs ( r = - 0.53, P = 0.12; r = - 0.37, P = 0.29). These results suggest that increased hepatic production of VLDL apoC-III is characteristic of subjects with higher body weights and lower levels of insulin sensitivity and is strongly related to the plasma concentration and level of production of VLDL TG.
引用
收藏
页码:3949 / 3955
页数:7
相关论文
共 61 条
[1]  
AaltoSetala K, 1996, J LIPID RES, V37, P1802
[2]   MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APOLIPOPROTEIN-(APO)-CIII TRANSGENIC MICE - DIMINISHED VERY LOW-DENSITY-LIPOPROTEIN FRACTIONAL CATABOLIC RATE ASSOCIATED WITH INCREASED APO-CIII AND REDUCED APO-E ON THE PARTICLES [J].
AALTOSETALA, K ;
FISHER, EA ;
CHEN, XL ;
CHAJEKSHAUL, T ;
HAYEK, T ;
ZECHNER, R ;
WALSH, A ;
RAMAKRISHNAN, R ;
GINSBERG, HN ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1889-1900
[3]   Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance [J].
Adeli, K ;
Taghibiglou, C ;
Van Iderstine, SC ;
Lewis, GF .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (05) :170-176
[4]   Familial HDL deficiency characterized by hypercatabolism of mature ApoA-I but not ProApoA-I [J].
Batal, R ;
Tremblay, M ;
Krimbou, L ;
Mamer, O ;
Davignon, J ;
Genest, J ;
Cohn, JS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (04) :655-664
[5]  
Batal R, 2000, J LIPID RES, V41, P706
[6]  
BROWN WV, 1972, BIOCHEM BIOPH RES CO, V46, P375
[7]   Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans [J].
Carpentier, A ;
Patterson, BW ;
Leung, N ;
Lewis, GF .
DIABETES, 2002, 51 (06) :1867-1875
[8]   Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration [J].
Chan, DC ;
Watts, GF ;
Redgrave, TG ;
Mori, TA ;
Barrett, PHR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (08) :1041-1046
[9]  
CHEN M, 1994, J LIPID RES, V35, P1918
[10]   MODULATION OF LIPOPROTEIN B BINDING TO THE LDL RECEPTOR BY EXOGENOUS LIPIDS AND APOLIPOPROTEIN-CI, APOLIPOPROTEIN-CII, APOLIPOPROTEIN-CIII, AND APOLIPOPROTEIN-E [J].
CLAVEY, V ;
LESTAVELDELATTRE, S ;
COPIN, C ;
BARD, JM ;
FRUCHART, JC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (07) :963-971